These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2561877)

  • 41. Hepatic phospholipids in alcoholic liver disease assessed by proton-decoupled 31P magnetic resonance spectroscopy.
    Schlemmer HP; Sawatzki T; Sammet S; Dornacher I; Bachert P; van Kaick G; Waldherr R; Seitz HK
    J Hepatol; 2005 May; 42(5):752-9. PubMed ID: 15826726
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Scintigraphy and angiography in demonstration of hepatic tumours.
    Bartley O; Helander CG; Rosengren B; Stattin S
    Acta Radiol Diagn (Stockh); 1969 Mar; 8(2):161-7. PubMed ID: 4308241
    [No Abstract]   [Full Text] [Related]  

  • 43. Nonalcoholic fatty liver disease: detection of elevated nicotinamide adenine dinucleotide phosphate with in vivo 3.0-T 31P MR spectroscopy with proton decoupling.
    Sevastianova K; Hakkarainen A; Kotronen A; Cornér A; Arkkila P; Arola J; Westerbacka J; Bergholm R; Lundbom J; Lundbom N; Yki-Järvinen H
    Radiology; 2010 Aug; 256(2):466-73. PubMed ID: 20656836
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatic cavernous hemangioma: appearance on T2-weighted fast spin-echo MR imaging with and without fat suppression.
    Soyer P; Dufresne AC; Somveille E; Scherrer A
    AJR Am J Roentgenol; 1997 Feb; 168(2):461-5. PubMed ID: 9016227
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The radiological investigation of primary hepatic tumours in infancy and childhood. A report of 8 cases.
    Meradji M
    J Belge Radiol; 1982; 65(1):1-8. PubMed ID: 6290443
    [No Abstract]   [Full Text] [Related]  

  • 46. Abnormal phosphomonoester signals in 31P MR spectra from patients with hepatic lymphoma. A possible marker of liver infiltration and response to chemotherapy.
    Dixon RM; Angus PW; Rajagopalan B; Radda GK
    Br J Cancer; 1991 Jun; 63(6):953-8. PubMed ID: 2069850
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatic cavernous hemangioma: magnetic resonance imaging. Work in progress.
    Glazer GM; Aisen AM; Francis IR; Gyves JW; Lande I; Adler DD
    Radiology; 1985 May; 155(2):417-20. PubMed ID: 3983393
    [TBL] [Abstract][Full Text] [Related]  

  • 48. T2-weighted MR imaging for focal hepatic lesion detection: supplementary value of breath-hold imaging with half-Fourier single-shot fast spin-echo and multishot spin-echo echoplanar sequences.
    Matsuo M; Kanematsu M; Murakami T; Kim T; Hori M; Kondo H; Nakamura H; Hoshi H
    J Magn Reson Imaging; 2000 Sep; 12(3):444-52. PubMed ID: 10992312
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lesion/fat intensity ratio in MR characterization of hepatic masses.
    Marti-Bonmati L; Torrijo C; Vilar J; Ronchera C; Paniagua JC; Talens A
    J Comput Assist Tomogr; 1991; 15(4):539-41. PubMed ID: 1648111
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MR imaging of hepatic focal nodular hyperplasia: characterization and distinction from primary malignant hepatic tumors.
    Mattison GR; Glazer GM; Quint LE; Francis IR; Bree RL; Ensminger WD
    AJR Am J Roentgenol; 1987 Apr; 148(4):711-5. PubMed ID: 3030082
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of focal hepatic masses by dynamic contrast-enhanced MR imaging: findings in 311 lesions.
    Quillin SP; Atilla S; Brown JJ; Borrello JA; Yu CY; Pilgram TK
    Magn Reson Imaging; 1997; 15(3):275-85. PubMed ID: 9201674
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Submillimeter-pixel MR images of hepatic cavernous hemangiomas.
    Maeda H; Hayashi N; Toyooka N; Endoh S; Hayashi R
    Radiat Med; 1997; 15(1):17-22. PubMed ID: 9134580
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of asymptomatic solitary hepatic lesions.
    Foster JH
    Annu Rev Med; 1988; 39():85-93. PubMed ID: 2835931
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Ultrasonic diagnosis of early cancer].
    Fukuda M
    Gan No Rinsho; 1988 Aug; 34(10):1525-33. PubMed ID: 2845171
    [No Abstract]   [Full Text] [Related]  

  • 55. Diagnostic value of diffusion weighted MRI and ADC in differential diagnosis of cavernous hemangioma of the liver.
    Tokgoz O; Unlu E; Unal I; Serifoglu I; Oz I; Aktas E; Caglar E
    Afr Health Sci; 2016 Mar; 16(1):227-33. PubMed ID: 27358636
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatic T2-weighted MRI: a prospective comparison of sequences, including breath-hold, half-Fourier turbo spin echo (HASTE).
    Coates GG; Borrello JA; McFarland EG; Mirowitz SA; Brown JJ
    J Magn Reson Imaging; 1998; 8(3):642-9. PubMed ID: 9626880
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molar quantitation of hepatic metabolites in vivo in proton-decoupled, nuclear Overhauser effect enhanced 31P NMR spectra localized by three-dimensional chemical shift imaging.
    Li CW; Negendank WG; Murphy-Boesch J; Padavic-Shaller K; Brown TR
    NMR Biomed; 1996 Jun; 9(4):141-55. PubMed ID: 9015801
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cavernous hemangioma of the liver.
    Olmsted WW; Stocker JT
    Radiology; 1975 Oct; 117(1):59-62. PubMed ID: 169544
    [No Abstract]   [Full Text] [Related]  

  • 59. Differentiation between hepatic cavernous hemangioma and malignant tumor with T2-weighted MRI: comparison of fast spin-echo and breathhold fast spin-echo pulse sequences.
    Soyer P; Dufresne AC; Somveille E; Lenormand S; Scherrer A; Rymer R
    Clin Imaging; 1998; 22(3):200-10. PubMed ID: 9559233
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dynamic gadolinium-DOTA-enhanced MR imaging at 1.0 T. Value in the differentiation of hepatic tumors.
    Soyer P; Laissy JP; Sibert A; Menu Y
    Clin Imaging; 1996; 20(2):118-25. PubMed ID: 8744821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.